Correlation Between Akero Therapeutics and Pieris Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Akero Therapeutics and Pieris Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akero Therapeutics and Pieris Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akero Therapeutics and Pieris Pharmaceuticals, you can compare the effects of market volatilities on Akero Therapeutics and Pieris Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akero Therapeutics with a short position of Pieris Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akero Therapeutics and Pieris Pharmaceuticals.
Diversification Opportunities for Akero Therapeutics and Pieris Pharmaceuticals
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Akero and Pieris is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Akero Therapeutics and Pieris Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pieris Pharmaceuticals and Akero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akero Therapeutics are associated (or correlated) with Pieris Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pieris Pharmaceuticals has no effect on the direction of Akero Therapeutics i.e., Akero Therapeutics and Pieris Pharmaceuticals go up and down completely randomly.
Pair Corralation between Akero Therapeutics and Pieris Pharmaceuticals
Given the investment horizon of 90 days Akero Therapeutics is expected to generate 0.65 times more return on investment than Pieris Pharmaceuticals. However, Akero Therapeutics is 1.54 times less risky than Pieris Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Pieris Pharmaceuticals is currently generating about 0.0 per unit of risk. If you would invest 4,402 in Akero Therapeutics on August 24, 2024 and sell it today you would lose (1,282) from holding Akero Therapeutics or give up 29.12% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Akero Therapeutics vs. Pieris Pharmaceuticals
Performance |
| Timeline |
| Akero Therapeutics |
| Pieris Pharmaceuticals |
Akero Therapeutics and Pieris Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akero Therapeutics and Pieris Pharmaceuticals
The main advantage of trading using opposite Akero Therapeutics and Pieris Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akero Therapeutics position performs unexpectedly, Pieris Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pieris Pharmaceuticals will offset losses from the drop in Pieris Pharmaceuticals' long position.| Akero Therapeutics vs. ZyVersa Therapeutics | Akero Therapeutics vs. Sonnet Biotherapeutics Holdings | Akero Therapeutics vs. Zura Bio Limited | Akero Therapeutics vs. Phio Pharmaceuticals Corp |
| Pieris Pharmaceuticals vs. Adaptimmune Therapeutics Plc | Pieris Pharmaceuticals vs. Mereo BioPharma Group | Pieris Pharmaceuticals vs. PDS Biotechnology Corp | Pieris Pharmaceuticals vs. Leap Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |